Health Law Daily Wrap Up, DRUGS AND BIOLOGICS—NOTICES: FDA releases annual report on postmarketing requirements and commitments, (Apr 28, 2026)

By WK Editorial Staff

The FDA announced the availability of the agency’s annual report entitled ‘‘Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments.”

Under the federal Food, Drug, and Cosmetic Act (FDC Act), the FDA is required to report annually on the status of postmarketing requirements (PMRs) and postmarketing commitments (PMCs) required of, or agreed upon by, application holders of approved drug and biological products. The report on the status of the studies and clinical trials that applicants are required to, or have agreed to, conduct is on the FDA’s website entitled ‘‘Postmarketing Requirements and Commitments: Reports” (Notice, 91 Fed. Reg. 22155 (Apr. 24, 2026)).

Dates. April 24, 2026.

FederalRegisterIssuances: Notices FDCActNews ClinicalNews DrugBiologicNews